Win For Barr In Glaucoma Drug IP Suit Upheld By Fed. Circ.
The Federal Circuit on Tuesday affirmed a lower court's ruling that generics maker Barr Laboratories Inc. did not infringe two Alcon Research Ltd. patents covering the glaucoma drug Travatan Z, but...To view the full article, register now.
Already a subscriber? Click here to view full article